
 |
 |
 |
 |
 |
|
Table 1
|
|
Expression
of cylicin II in normal human tissues and neoplasms.
|
Normal
tissues
|
#
positive / # tested
|
Neoplasms
|
#
positive / # tested
|
|
Breast
|
0/3
|
Bladder
carcinoma
|
0/1
|
|
Colon
|
0/2
|
Breast
Cancer
|
0/14
|
|
Intestine
|
0/1
|
Colorectal
carcinoma
|
0/7
|
|
Myocardium
|
0/3
|
Endometrial
carcinoma
|
1/9
|
|
Liver
|
0/2
|
Gastric
cancer
|
0/2
|
|
Lymph
node
|
0/5
|
Glioma
|
0/9
|
|
Lung
|
0/3
|
Leiomyoma
|
0/1
|
|
Kidney
|
0/2
|
Lung
cancer
|
0/11
|
|
Ovary
|
0/1
|
Lymphoma
|
1/19
|
|
Pancreas
|
0/1
|
Melanoma
|
0/5
|
|
PBL
|
0/1
|
Meningioma
|
0/4
|
|
PBL
activated
|
0/1
|
Neuroblastoma
|
0/1
|
|
Skeletal
muscle
|
0/1
|
Ovarian
Cancer
|
0/14
|
|
Spleen
|
0/4
|
Pancreatic
carcinoma
|
0/1
|
|
Stomach
|
0/1
|
Prostate
cancer
|
0/1
|
|
Testis
|
2/2
|
Renal
carcinoma
|
1/13
|
|
Thyroid
|
0/2
|
T-ALL
(spleen)
|
1/1
|
|
Tonsil
|
0/5
|
|
|
|
|
 |
 |
 |
 |
Copyright
© 2001 by Michael Pfreundschuh